Effect of late modulation of nitric oxide production on murine lupus

Clinical Immunology and Immunopathology

Volumn 83, Issue 1, 1997, Pages 86-92

  Oates, James C ^a   Ruiz, Philip ^b   Alexander, Audrey ^c   Pippen, Anne M M ^c   Gilkeson, Gary S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIET; ETIOLOGY; FEMALE; GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031127933     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4332     Document Type: Article

References (35)

1. 1. Lowenstein, C. J., Dinerman, J. L., and Snyder, S. H., Nitric oxide: A physiologic messenger. Ann. Intern. Med. 120, 227-237, 1994.
2. 2. Moilanen, E., and Vapaatalo, H., Nitric oxide in inflammation and immune response. Ann. Med. 27, 359-367, 1995.
3. 3. Moncada, S., and Higgs, A., The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329, 2002-2012, 1993.
4. 4. Forstermann, U., and Dun, N. J., Immunohistochemical localization of nitric oxide synthases. Methods Enzymol. 268, 510-515, 1996.
5. 5. Stamler, J. S., Singel, D. J., and Loscalzo, J., Biochemistry of nitric oxide and its redox-activated forms. Science 258, 1898-1902, 1992.
6. 6. Privalle, C. T., Keng, T., Gilkeson, G. S., and Weinberg, J. B., The role of nitric oxide and peroxynitrite in the pathogenesis of spontaneous murine autoimmune disease. In "The Biology of Nitric Oxide" (Stamler, J., Gross, S. S., and Moncada, S. Eds.), Elsevier Press, New York, NY (in press).
7. 7. Liew, F. Y., The role of nitric oxide in parasitic diseases. Ann. Trop. Med. Parisitol. 87, 637-642, 1993.
8. 8. van der Meide, P. H., de Labie, M. C. D. C., Botman, C. A. D., Aten, J., and Weening, J. J., Nitric oxide suppresses IFN-γ production in the spleen of mercuric chloride-exposed brown Norway rats. Cell. Immunol. 161, 195-206, 1995.
9. 9. Taylor-Robinson, A. W., Liew, F. Y., Severn, A., Xu, D., McSorley, S. J., Garside, P., Padron, J., and Phillips, R. S., Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24, 980-984, 1994.
10. 10. Gilkeson, G. S., Cannon, C., Goldman, D., and Petri, M., Correlation of a serum measure of nitric oxide production with lupus disease activity measures. Arthritis Rheum. 39, s251, 1996.
11. 11. Miesel, R., and Zuber, M., Reactive nitrogen intermediates, antinuclear antibodies and copper theonein in serum of patients with rheumatic diseases. Rheum. Int. 12, 95-102, 1993.
12. 12. Kashem, A., Endoh, M., Yano, N., Yamauchi, F., Nomoto, Y., and Sakai, H., Expression of inducible-NOS in human glomerulonephritis: The possible source is infiltrating monocytes/macrophages. Kidney Int. 50, 392-399, 1996.
13. 13. Sakurai, H., Kohsaka, H., Lui, M. F., Higashiyama, H., Hirata, Y., Kanno, K., Siato, I., and Miyasaka, N., Nitric oxide production an inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96, 2357-2363, 1995.
14. 14. Farrell, A. J., Blake, D. R., Palmer, R. M., and Moncada, S., Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51, 1219-1222, 1992.
15. 15. St. Glair, E. W., Wilkinson, W. E., Lang, T., Sanders, L., Misukonis, M. A., Gilkeson, G. S., Pisetsky, D. S., Granger, D. L., and Weinberg, J. B., Systemic activation for nitric oxide synthase expression and nitric oxide production in rheumatoid arthritis. J. Exp. Med. 184, 1173-1178, 1996.
16. 16. Vladutiu, A. O., Role of nitric oxide in autoimmunity. Clin. Immunol. Immunopathol. 76, 1-11, 1995.
17. 17. Narita, I., Border, W. A., Ketteler, M., Ruoslahti, E., and Noble, N. A., L-Arginine may mediate the therapeutic effects of low protein diets. Proc. Natl. Acad. Sci. USA 92, 4552-4556, 1995.
18. 18. Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., Murphy, E. D., Roths, J. B., and Dixon, F. J., Spontaneous murine lupus-like syndromes: Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148, 1198-1215, 1978.
19. G-monomethyl-L-arginine. J. Exp. Med. 179, 651-660, 1994.
20. 20. Schmidt, K., Klatt, P., and Mayer, B., Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells. Biochem. J. 301, 313-316, 1994.
21. G-mono-methyl-L-arginine. J. Immunol. 146, 1294-1302, 1991.
22. 22. Moshage, H., Kok, B., Huizenga, J. R., and Jansen, P. L. M., Nitrite and nitrate determinations in plasma: A critical evaluation. Clin. Chem. 41, 892-896, 1995.
23. 23. Gilkeson, G. S., Grudier, J. P., Karounos, D. G., and Pisetsky, D. S., Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J. Immunol. 142, 1482-1486, 1989.
24. 24. Gilkeson, G. S., Ruiz, P., Grudier, J. P., Kurlander, R. J., and Pisetsky, D. S., Genetic control of inflammatory arthritis in congenic lpr mice. Clin. Immunol. Immunopathol. 53, 460-474, 1989.
25. 25. Gilkeson, G. S., Ruiz, P., Pippen, A. M. M., Alexander, A., Lefkowith, J. B., and Pisetsky, D. S., Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Exp. Med. 183, 1389-1397, 1996.
26. 26. Sugimura, K., Wada, Y., Kimura, T., Ohno, T., Kobayashi, S., and Azuma, I., Inherited hyperactivation of L-arginine synthesis in gamma + B lymphocytes of systemic autoimmune MRL mice. Int. Immunol. 2, 1033-1038, 1990.
27. 27. Hibbs, J. B., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baronowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., Kushner, J. P., et al., Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89, 867-877, 1992.
28. 28. Hewicker, M., and Trautwein, G., Glomerular lesions in MRL mice: A light and immunofluorescence microscopic study. J. Vet. Med. B 33, 727-739, 1986.
29. 29. Hang, L., Theofilopoulos, A. N., and Dixon, F. J., A spontaneous rheumatoid arthritis-like disease in MRL/lpr mice. J. Exp. Med. 155, 1690-1701, 1982.
30. 30. O'Sullivan, F. X., Fassbender, H. G., Gay, S., and Koopman, W. J., Etiopathogenesis of rheumatoid arthritis-like disease in MRL/lpr mice. I. The histomorphologic basis of joint destruction. Arthritis Rheum. 28, 529-536, 1985.
31. 31. Watson, M. L., Rao, J. K, Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., Matsuzawa, A., Rochelle, J. M., and Seldin, M. F., Genetic analysis of MRL-lpr mice: Relationship of Fas apoptosis gene to disease manifestations of renal disease-modifying loci. J. Exp. Med. 176, 1645-1656, 1992.
32. 32. Nose, M., Nishimura, M., and Kyogoku, M., Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes: The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis. Am. J. Pathol. 135, 271-280, 1989.
33. 33. Takahashi, S., Fossati, L., Iwamoto, M., Merino, R., Motta, R., Kobayakawa, T., and Izui, S., Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97, 15997-1604, 1996.
34. 34. Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., and Howard, M., Continuous administration of anti-interleukin-10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179, 305-310, 1994.
35. 35. Brennan, D. C., Yui, M. A., Wuthrich, R. P., and Kelley, B. E., Tumor necrosis factor and IL-1 in New Zealand Black/White mice: Enhanced gene expression and acceleration of renal injury. J. Immunol. 143, 3470-3475, 1989.